1 Result(s)

Article

Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients

Proteasome inhibitors (PIs), including carfilzomib, potentiate the activity of selinexor, a novel, first-in-class, oral selective inhibitor of nuclear export (SINE) compound, in preclinical models of multiple ...

Cristina Gasparetto, Gary J. Schiller, Sascha A. Tuchman… in British Journal of Cancer (2022)